Literature DB >> 3091169

Treatment of functional abdominal pain by transcutaneous electrical nerve stimulation.

K Sylvester, G P Kendall, J E Lennard-Jones.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3091169      PMCID： PMC1341113          DOI： 10.1136/bmj.293.6545.481-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

1.  Relief of pain by transcutaneous stimulation.

Authors:  J D Loeser; R G Black; A Christman
Journal:  J Neurosurg       Date:  1975-03       Impact factor: 5.115

2.  The placebo effect of transcutaneous electrical stimulation.

Authors:  Gudni Thorsteinsson; Henry H Stonnington; Keith G Stillwell; Lila R Elveback
Journal:  Pain       Date:  1978-06       Impact factor: 6.961

3.  Towards positive diagnosis of the irritable bowel.

Authors:  A P Manning; W G Thompson; K W Heaton; A F Morris
Journal:  Br Med J       Date:  1978-09-02
  3 in total
  5 in total

Review 1.  The irritable bowel syndrome.

Authors:  C Y Francis; P J Whorwell
Journal:  Postgrad Med J       Date:  1997-01       Impact factor: 2.401

2.  Pain management in patients with inflammatory bowel disease: insights for the clinician.

Authors:  Arvind Iyengar Srinath; Chelsea Walter; Melissa C Newara; Eva M Szigethy
Journal:  Therap Adv Gastroenterol       Date:  2012-09       Impact factor: 4.409

3.  Is transcutaneous electrical nerve stimulation an effective analgesia during colonoscopy?

Authors:  R Robinson; S Darlow; S J Wright; C Watters; I Carr; G Gadsby; J Mayberry
Journal:  Postgrad Med J       Date:  2001-07       Impact factor: 2.401

Review 4.  Visceral chest pain in unstable angina pectoris and effects of transcutaneous electrical nerve stimulation. (TENS). A review.

Authors:  M Börjesson
Journal:  Herz       Date:  1999-04       Impact factor: 1.443

Review 5.  Diagnosis and management of irritable bowel syndrome: discussion paper.

Authors:  P J Whorwell
Journal:  J R Soc Med       Date:  1989-10       Impact factor: 18.000
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.